Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Chromosomal Analysis of Single Cells in Human Embryos

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2008 by Katholieke Universiteit Leuven.
Recruitment status was:  Active, not recruiting
Sponsor:
Information provided by:
Katholieke Universiteit Leuven
ClinicalTrials.gov Identifier:
NCT00614367
First received: January 30, 2008
Last updated: February 11, 2008
Last verified: January 2008
  Purpose
Optimise genetic screening of human embryos using higher resolution techniques

Condition
Chromosomal Abnormalities

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Chromosomal Analysis of Single Cells in Human Embryos

Further study details as provided by Katholieke Universiteit Leuven:

Primary Outcome Measures:
  • genetic constitution of single blastomeres [ Time Frame: 3 day old embryos ]

Biospecimen Retention:   Samples With DNA
Single blastomeres of human embryos

Enrollment: 30
Study Start Date: October 2005
Estimated Study Completion Date: June 2008
Estimated Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   up to 4 Days   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
3-4 day old human IVF embryos
Criteria

Inclusion Criteria:

  • 3-4 day old embryos from IVF couples with both partners younger than 36 years old
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00614367

Locations
Belgium
University Hospital Leuven, Catholic University Leuven
Leuven, Belgium, 3000
Sponsors and Collaborators
Katholieke Universiteit Leuven
Investigators
Principal Investigator: Joris Vermeesch, Prof PhD University Hospital Leuven, Catholic University Leuven
Study Director: Thomas D'hooghe, Prof MD PhD Universitaire Ziekenhuizen Leuven
  More Information

Responsible Party: Prof Joris Vermeesch, University Hospital Leuven - Catholic University Leuven
ClinicalTrials.gov Identifier: NCT00614367     History of Changes
Other Study ID Numbers: ML4102005
Study First Received: January 30, 2008
Last Updated: February 11, 2008

Keywords provided by Katholieke Universiteit Leuven:
chromosomal abnormalities in single cells

Additional relevant MeSH terms:
Congenital Abnormalities
Chromosome Aberrations
Chromosome Disorders
Pathologic Processes
Genetic Diseases, Inborn

ClinicalTrials.gov processed this record on May 25, 2017